Impact of a cholesterol enriched diet on maternal and fetal plasma lipids and fetal deposition in pregnant rabbits.
Pregnancy is associated with a hypercholesterolemic and a hyperlipidemic state. The totality of the essential fatty acids and 50% of the lipids needed by the fetus are transferred by the placenta from the maternal circulation. The hypothesis of this study is that an augmentation of the maternal plasmatic cholesterol is modifying the fetal lipids accumulation and development during rabbit pregnancy. To demonstrate the impact of a cholesterol enriched diet on plasma lipids during rabbit's pregnancy and on their fetus, we have established two groups: control and hypercholesterolemic rabbits (fed with a 0.2% cholesterol diet). Blood samples were collected before mating and at each trimester of pregnancy for analysis of lipid fractions and their lipoproteins. Plasma analysis shows that starting the 10th day of pregnancy the concentration of total-cholesterol and lipoproteins decreases for both groups. We have demonstrated that for the hypercholesterolemic group, concentrations of total-cholesterol (631%) and lipoproteins are significantly higher at the end of pregnancy than those for the control group. For both groups, after 20 days of pregnancy, triglycerides metabolism was biphasic showing a significant increase followed by a diminution in their concentration. In both groups, free fatty acids increases significantly at the end of the pregnancy (537.5% for the control group and 462.5% for the hypercholesterolemic group). Furthermore, the offsprings of hypercholesterolemic dams manifest a lower birth weight (15.5%) than those of control group. Our results demonstrate that a cholesterol enriched diet modifies greatly the fetal development and lipid metabolism during rabbit's pregnancy. These modifications could be useful for the understanding of the interaction between diet and fetal development in rabbit and probably during human pregnancy.
Département des Sciences Biologiques, Université du Québec à Montréal, Canada.
A
A
Montoudis
L
L
Simoneau
L
L
Brissette
J C
JC
Forest
R
R
Savard
J
J
Lafond
D000818:Animals; D001835:Body Weight / Q000187:drug effects; D002784:Cholesterol / Q000097:blood; D002791:Cholesterol, Dietary / Q000494:pharmacology*; D005314:Embryonic and Fetal Development / Q000187:drug effects*; D005227:Fatty Acids / Q000097:blood; D005260:Female; D005312:Fetal Blood; D005333:Fetus / Q000378:metabolism*; D005990:Glycerol / Q000097:blood; D006937:Hypercholesterolemia / Q000097:blood* / Q000139:chemically induced / Q000196:embryology / Q000473:pathology; D008055:Lipids / Q000097:blood*; D010920:Placenta / Q000187:drug effects / Q000473:pathology; D011247:Pregnancy; D011817:Rabbits; D012709:Serum Albumin / Q000032:analysis; D014280:Triglycerides / Q000097:blood
D002791:Cholesterol, Dietary; D005227:Fatty Acids; D008055:Lipids; D012709:Serum Albumin; D014280:Triglycerides; D002784:Cholesterol; D005990:Glycerol